Yukio Hosomi

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 13

Top Topics

Roux En Y Gastric Bypass

Small Cell Lung Cancer

Metastatic Colorectal Cancer

Top Venues

Thoracic cancer

Translational lung cancer research

Journal of cancer research and clinical oncology

International journal of clinical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Kazuhito Misawa, Kageaki Watanabe, Masahiro Seike, Yukio Hosomi
Durvalumab plus platinum-etoposide chemotherapy for extensive-stage small cell lung cancer: a retrospective real-world study. Translational lung cancer research 13 (7) (2024)
Shigehiro Yagishita, Yuta Yamanaka, Takayasu Kurata, Kageaki Watanabe, Yukio Hosomi, Hidehito Horinouchi, Yuichiro Ohe, Yoshiro Nakahara, Katsuhiko Naoki, Tetsuhiko Asao, Kazuhisa Takahashi, Sho Saeki, Takuro Sakagami, Kazuhisa Nakashima, Yukari Tsubata, Yu Fujita, Kazuyoshi Kuwano, Megumi Furuta, Jun Sakakibara Konishi, Mayu Ohuchi, Yuichi Ando, Hidenori Mizugaki, Akinobu Hamada
Multicenter Pharmacokinetic and Pharmacodynamic Study of Pembrolizumab for Non-small-Cell Lung Cancer in Patients Aged 75 Years and Older. Clinical pharmacology and therapeutics (2024)
Kazuhito Misawa, Kageaki Watanabe, Masahiro Seike, Yukio Hosomi
Durvalumab plus platinum-etoposide chemotherapy for extensive-stage small cell lung cancer: a retrospective real-world study. Translational lung cancer research 13 (7) (2024)
Yuto Terashima, Taiki Hakozaki, Yuji Uehara, Akihiko Miyanaga, Kazuo Kasahara, Masahiro Seike, Yukio Hosomi
Prognostic significance of initial tumor shrinkage in patients with stage III non-small cell lung cancer treated with durvalumab following chemoradiotherapy. International journal of clinical oncology (2023)
Taiki Hakozaki, Alexis Nolin-Lapalme, Masato Kogawa, Yusuke Okuma, Shohei Nakamura, Danielle Moreau-Amaru, Taichi Tamura, Yukio Hosomi, Haruko Takeyama, Corentin Richard, Masahito Hosokawa, Bertrand Routy
Cancer Cachexia among Patients with Advanced Non-Small-Cell Lung Cancer on Immunotherapy: An Observational Study with Exploratory Gut Microbiota Analysis. Cancers 14 (21) (2022)
Yuji Uehara, Kageaki Watanabe, Taiki Hakozaki, Makiko Yomota, Yukio Hosomi
Efficacy of first-line immune checkpoint inhibitors in patients with advanced NSCLC with KRAS, MET, FGFR, RET, BRAF, and HER2 alterations. Thoracic cancer 13 (11) (2022)
Yasushi Goto, Kiyotaka Yoh, Terufumi Kato, Yukio Hosomi, Kazuhiro Usui, Tomoya Fukui, Katsuya Hirano, Hiroshi Tanaka, Masataka Taguri, Hideo Kunitoh
Observational study to predict the efficacy and optimal duration of nivolumab treatment in patients with previously treated advanced or recurrent non-small cell lung cancer. Japanese journal of clinical oncology (2022)
Eisaku Miyauchi, Satoshi Morita, Atsushi Nakamura, Yukio Hosomi, Kana Watanabe, Satoshi Ikeda, Masahiro Seike, Yuka Fujita, Koichi Minato, Ryo Ko, Toshiyuki Harada, Koichi Hagiwara, Kunihiko Kobayashi, Toshihiro Nukiwa, Akira Inoue, null null
Updated Analysis of NEJ009: Gefitinib-Alone Versus Gefitinib Plus Chemotherapy for Non-Small-Cell Lung Cancer With Mutated EGFR . Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (31) (2022)
Yukio Hosomi, Takashi Seto, Makoto Nishio, Koichi Goto, Noboru Yamamoto, Isamu Okamoto, Kosei Tajima, Yusuke Kajihara, Nobuyuki Yamamoto
Erlotinib with or without bevacizumab as a first-line therapy for patients with advanced nonsquamous epidermal growth factor receptor-positive non-small cell lung cancer: Exploratory subgroup analyses from the phase II JO25567 study. Thoracic cancer 13 (15) (2022)
Yuto Terashima, Taiki Hakozaki, Susumu Takeuchi, Yukio Hosomi
Lenvatinib rechallenge in a patient with advanced thymic carcinoma: A case report. Thoracic cancer 13 (23) (2022)
Shoko Kawai, Kageaki Watanabe, Maiko Asai, Kana Hashimoto, Taiki Hakozaki, Kosuke Narita, Makiko Yomota, Yukio Hosomi
A case series on the safety of immunotherapy with reduced blood testing frequency in lung cancer patients. International journal of clinical oncology 26 (5) (2021)
Taiki Hakozaki, Yukio Hosomi, Rui Kitadai, Shingo Kitagawa, Yusuke Okuma
Efficacy of immune checkpoint inhibitor monotherapy for patients with massive non-small-cell lung cancer. Journal of cancer research and clinical oncology 146 (11) (2020)
Taiki Hakozaki, Yukio Hosomi, Akihiro Shimizu, Rui Kitadai, Kie Mirokuji, Yusuke Okuma
Polypharmacy as a prognostic factor in older patients with advanced non-small-cell lung cancer treated with anti-PD-1/PD-L1 antibody-based immunotherapy. Journal of cancer research and clinical oncology 146 (10) (2020)